DIAZEPINOMICIN

DIAZEPINOMICIN Uses, Dosage, Side Effects, Food Interaction and all others data.

DIAZEPINOMICIN has been used in trials studying the treatment of Glioblastoma Multiforme. It is a proprietary first-in-class small molecule with the potential to treat multiple solid tumours like the well known chemotherapeutics, doxorubicin and mitomycin C. DIAZEPINOMICIN is a natural product derived from a non-pathogenic micro-organism. Discovered using Thallion’s DECIPHER technology, diazepinomicin has completed preclinical studies conducted by the National Cancer Institute and Thallion to establish safety and efficacy in animal and in vitro models.

Trade Name	DIAZEPINOMICIN
Generic	Diazepinomicin
Diazepinomicin Other Names	DIAZEPINOMICIN
Type
Formula	C28H34N2O4
Weight	Average: 462.59 Monoisotopic: 462.251857583
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

How DIAZEPINOMICIN works

DIAZEPINOMICIN demonstrates broad in vitro cytotoxic activity across a diverse panel of tumour cell lines and in vivo efficacy in a number of xenograft tumour models. Preclinical data suggest that diazepinomicin is a targeted anti-cancer agent with dual activity: selective binding to the peripheral benzodiazepine receptor (PBR) and inhibition of the Ras-MAPK pathway.

Innovators Monograph

You find simplified version here DIAZEPINOMICIN